Tom Callaway MD, MBA
President and Founder
Tom is the Founder and President of Life Science Partner, an executive recruiting firm specializing in placing senior executives within the medical device, pharmaceutical, and biotech industries. Prior to starting Life Science Partner, he led the Emerging Health Technologies practice at Korn/Ferry International, where he was Managing Director. Tom primarily recruited top-level executives for and at Russell Reynolds where he earned a reputation for quickly grasping new technologies and successfully recruiting top scientists and business leaders.
Tom is also a partner in two venture funds: Georgia Venture Partners, a seed stage fund based in Atlanta, and a new fund HealthQuest Capital (HQC) that is funding venture growth stage medical device, diagnostics, healthcare IT, and consumer healthcare companies. HQC is especially interested in innovations that provide benefits that can be quantified in terms of both improvements in patient care and outcomes, as well as healthcare economics. While HealthQuest Capital invests anywhere in North America, the partners have a strong interest in the Southeastern US or the West Coast.
Prior to his career in executive placement, Tom served as Director of Commercial Development for SyStemix, where he established technology developmental partnerships with major cancer centers including M.D. Anderson, Fred Hutchinson Cancer Research Center, and the Mayo Clinic. SyStemix developed proprietary stem cell purifying technologies important for treatment of cancer and genetic illnesses. He was the liaison with Sandoz’s oncology group, whose parent company completed its acquisition of the company in 1996.
Tom began his biotechnology career at Roche Biomedical and Roche Molecular Systems, developing and executing a global marketing plan for polymerase chain reaction (PCR) diagnostics technology. In partnership with Duke University Medical Center, Tom conceived and organized the first international conference on the clinical applications of PCR for HIV detection.
Tom earned his Medical Degree at Vanderbilt University and both his undergraduate degree and MBA at Duke University. Active in the Southeast community, he was the chairman of Georgia BIO 2013, sits on the boards of Southeast BIO, and of the Park H. Petit Institute for Bioengineering and Bioscience at Georgia Tech, and helped found the Southeast Medical Device Association (semda.net). Tom also served on the Georgia BIO committee that hosted the 2009 BIO International Convention in Atlanta.